Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Van Epps

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Developments in Biologicals|December 18, 2004
Characterization of polyvalent allogeneic vaccinesD Van Epps
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormoneM J Mason, D Van Epps
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Leukocyte specificity and binding of human neutrophil attractant/activation protein-1E J Leonard, A Skeel, T Yoshimura, et al.
Experimental Hematology|May 26, 1999
Identification of a peptide directed against the anti-CD34 antibody, 9C5, by phage display and its use in hematopoietic stem cell selectionJ Tseng-Law, P Szalay, R Guillermo, et al.
The American Journal of Physiology|November 1, 1988
Regionally variable pulmonary artery responses to C3aR E Crowell, W P Reed, D Van Epps, et al.
Experimental Hematology|September 1, 1995
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometryS J Simpson, M Vachula, M J Kennedy, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumorsM Sen, D M Wankowski, N K Garlie, et al.
Bone Marrow Transplantation|April 1, 1994
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimensJ G Bender, L Lum, K L Unverzagt, et al.
Blood|March 1, 1996
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancerS F Williams, W J Lee, J G Bender, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Developments in Biologicals|December 18, 2004
Characterization of polyvalent allogeneic vaccinesD Van Epps
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormoneM J Mason, D Van Epps
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Leukocyte specificity and binding of human neutrophil attractant/activation protein-1E J Leonard, A Skeel, T Yoshimura, et al.
Experimental Hematology|May 26, 1999
Identification of a peptide directed against the anti-CD34 antibody, 9C5, by phage display and its use in hematopoietic stem cell selectionJ Tseng-Law, P Szalay, R Guillermo, et al.
The American Journal of Physiology|November 1, 1988
Regionally variable pulmonary artery responses to C3aR E Crowell, W P Reed, D Van Epps, et al.
Experimental Hematology|September 1, 1995
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometryS J Simpson, M Vachula, M J Kennedy, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumorsM Sen, D M Wankowski, N K Garlie, et al.
Bone Marrow Transplantation|April 1, 1994
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimensJ G Bender, L Lum, K L Unverzagt, et al.
Blood|March 1, 1996
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancerS F Williams, W J Lee, J G Bender, et al.
Pageof 1